VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
USPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
USPHU.S. Physical Therapy, Inc.
$83.17$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUSPHCash Flow

U.S. Physical Therapy, Inc. (USPH) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow consistently exceeds net income with a 10-quarter average OCF/NI ratio of 1.64, yet free cash flow is volatile, ranging from -4.8% to 19.7% of revenue, as aggressive deployment for acquisitions ($52.5M) and shareholder returns ($53.7M) has depleted cash reserves to $24.9M.

Income StatementBalance SheetCash FlowRatios

USPH Cash Flow Statement

Annual statement

USPH Cash Flow Statement

U.S. Physical Therapy, Inc. (USPH) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations87.05M75.06M74.94M81.98M58.54M76.41M100M62.45M73M56.53M51.05M41.24M45.19M44.8M39.25M32.66M30.52M30.94M30.17M19.05M18.47M18.25M17.88M17.53M19.52M15.17M8.86M5.05M5M3.8M4.7M
Operating CF Margin %-9.61%11.16%13.55%10.58%15.43%23.64%12.96%16.08%13.65%14.32%12.45%14.81%16.96%15.57%13.78%14.45%15.36%16.08%12.56%13.66%13.81%15.12%16.61%20.61%18.74%14.02%10.11%11.36%9.79%14.6%
Operating CF Growth %213.74%0.16%-8.59%40.04%-23.39%-23.59%60.13%-14.46%29.15%10.73%23.78%-8.74%0.89%14.13%20.19%6.99%-1.37%2.56%58.41%3.11%1.21%2.06%2.01%-10.2%28.68%71.22%75.47%1%31.58%-19.15%95.83%
Net Income2.26M58.01M45.6M37.22M43.41M57.92M52.49M57.26M48.84M27.72M26.27M31.69M30.42M21M26.22M29.78M24.7M19.97M10M8.74M6.3M8.79M6.68M7.33M8.49M7.07M3.73M2.39M1.6M2.4M1.6M
Depreciation & Amortization28.4M22.39M18.68M15.7M14.74M11.59M10.53M10.1M9.76M9.71M8.78M7.95M6.74M5.56M5.29M5.45M5.67M5.9M5.97M4.99M4.49M4.31M4.32M3.59M2.96M2.57M2.33M2.09M2.1M1.9M1.7M
Stock-Based Compensation9.86M8.27M7.82M7.24M7.26M7.87M7.92M6.99M5.94M5.03M4.96M4.49M3.36M2.74M2.1M2.03M1.29M1.57M1.57M1.28M1.04M0000000000
Deferred Taxes12.65M11.41M5.37M4.49M4.31M5.69M-258K4.65M4.81M-4.55M2.98M7M6.28M2.37M3.74M3.83M452K714K1.92M313K-373K44K146K474K-319K-351K00300K00
Other Non-Cash Items29.56M2.18M9.88M22.27M10.24M5.12M5.67M-560K2.92M4.29M4.19M3.49M3.33M11.02M6.37M-1.25M2.16M2.93M9.93M7.84M8.16M7.06M7.79M8.01M10.83M10.25M5.35M3.75M-100K2.8M2.1M
Working Capital Changes-37.88M-27.19M-12.4M-4.93M-21.43M-11.78M23.64M-15.98M732K14.32M3.87M-13.38M-4.94M2.1M-4.47M-7.19M-3.75M-148K772K-4.11M-1.15M-1.95M-1.05M-1.87M-2.43M-4.36M-2.56M-3.19M-2.1M-3.3M-700K
Change in Receivables-7.67M-9.06M-11.89M-6M-10.28M-10.96M2.56M-6.38M-3.43M-3.45M-3.27M-5.52M-5.39M-5.39M-1.66M-6.14M-4.47M-303K-1.57M-3.54M-3.43M-3.22M000000000
Change in Inventory00000004.21M-742K-794K-1.45M-2.33M-2.15M1.8M-1.15M0-24.04M-19.97M252K-87K-73K-29.5M000000000
Change in Payables-8.88M-7.8M015K-7.75M00-4.21M4.88M6.98M2.99M-7.01M1.87M4.83M-340K1.19M-292K1.87M1.87M-655K1.62M1.04M000000000
Cash from Investing-103.58M-36.71M-149.45M-45.02M-81.27M-124.14M-51.2M-37.99M-23.91M-43.58M-32.49M-32.24M-22.88M-52.45M-14.1M-31.61M-21.63M-7.33M-24.88M-23.54M-8.85M-12.18M-4.96M-5.03M-6.63M-3.38M-2.8M-2.1M-2.5M-2.1M-2M
Capital Expenditures-24.35M-14.07M-9.19M-9.29M-8.25M-8.2M-7.64M-10.19M-7.19M-7.09M-8.26M-6.26M-5.17M-4.64M-4.23M-3.22M-3.67M-3.88M-4.3M-4.03M-4.66M-10.85M-4.97M-5.13M-5.57M-3.34M-2.83M-2.1M-2.4M-1.8M-2M
CapEx % of Revenue3.46%1.8%1.37%1.54%1.49%1.66%1.81%2.11%1.58%1.71%2.32%1.89%1.69%1.76%1.68%1.36%1.74%1.92%2.29%2.66%3.44%8.21%4.2%4.86%5.87%4.13%4.47%4.2%5.45%4.64%6.21%
Acquisitions-66.29M-24.95M-142.04M-36.87M-74.28M-116.09M-43.56M-27.87M-16.37M-36.56M-24.29M-26.05M-17.76M-48.5M-10.17M-9.45M-17.28M-1.18M-20.68M-20.02M-5.21M-1.51M000000000
Investments-------------------------------
Other Investing-12.95M2.31M1.77M1.15M1.26M152K064K-349K81K61K71K5.54M2.33M303K-18.93M-17.96M57K108K21K-1.14M178K11K105K-1.07M-32K25K1K-100K-300K0
Cash from Financing199K-44.14M-36.95M84.27M25.76M43.38M-39.42M-24.27M-47.66M-11.06M-14.29M-7.5M-20.94M8.88M-23.46M-245K-6.14M-27.3M-3.16M1.51M-11.03M-11.62M-9.19M-3.29M-13.4M-5.75M-8.02M-5.25M-1.7M-1.1M-500K
Debt Issued (Net)102M8.06M4.3M-39.15M64.19M93.1M-31.04M6.57M-20.04M6.77M1.2M8.62M-6.33M22.14M-6.53M17.75M4.09M-12.38M3.51M6.41M-245K-153K-52K-38K-701K-1.54M862K-32K-100K-100K200K
Equity Issued (Net)-24.8M-5.57M0163.65M00000000000-4.66M-1.4M-5.59M495K568K-5.4M-6.2M-3.81M1.44M-7.51M336K-5.88M-3.28M000
Dividends Paid-27.55M-27.36M-26.54M-24.13M-21.32M-18.77M-4.11M-14.55M-11.66M-10.07M-8.51M-7.45M-5.87M-4.84M-9.02M-3.79M-9.58M-9.44M0000000000000
Share Repurchases-24.8M-5.57M00000502K0000000-4.66M-1.4M-5.59M00-5.52M-8M-5.58M-20K-10.51M-1.94M-6.28M-3.41M000
Other Financing-49.44M-19.27M-14.71M-16.1M-17.11M-30.96M-4.28M-16.29M-15.95M-7.77M-6.98M-4.94M-8.74M-8.42M-7.91M-9.55M-8.82M101K128K-5.47M-5.38M-5.27M-5.33M-4.7M-5.19M-4.54M-3M-1.94M-1.6M-1M-700K
Net Change in Cash-16.33M-5.79M-111.46M121.23M3.03M-4.35M9.37M180K1.44M1.89M4.27M1.51M1.37M1.23M1.69M804K2.75M-3.68M2.14M-2.98M-1.4M-5.55M3.73M9.21M-511K6.05M-1.96M-2.3M800K600K2.2M
Free Cash Flow62.7M60.99M65.75M72.68M50.29M68.2M92.36M52.26M65.81M49.43M42.79M34.98M40.03M40.16M35.02M29.43M26.85M27.07M25.87M15.01M13.82M7.4M12.91M12.4M13.96M11.83M6.03M2.95M2.6M2M2.7M
FCF Margin %8.9%7.81%9.79%12.02%9.09%13.78%21.84%10.84%14.5%11.94%12%10.56%13.12%15.21%13.89%12.42%12.71%13.44%13.79%9.9%10.22%5.6%10.92%11.74%14.73%14.61%9.54%5.91%5.91%5.15%8.39%
FCF Growth %3%-7.25%-9.53%44.53%-26.27%-26.15%76.73%-20.59%33.14%15.52%22.33%-12.61%-0.33%14.69%18.97%9.63%-0.81%4.62%72.34%8.66%86.62%-42.67%4.15%-11.18%18.02%96.02%104.33%13.58%30%-25.93%200%
FCF per Share4.154.024.365.123.875.297.204.105.203.933.422.823.283.322.942.462.262.292.151.281.180.611.041.031.100.920.560.300.240.180.26
FCF Conversion (FCF/Net Income)27.71x4.98x2.83x5.59x2.07x2.75x3.27x2.22x7.23x2.54x2.48x1.85x2.29x3.52x2.19x1.56x1.95x2.63x3.02x2.14x2.93x2.08x2.68x2.39x2.30x2.15x2.37x2.11x3.13x1.58x2.94x
Interest Paid2.62M9.43M7.21M8.65M5.69M1.35M1.2M1.89M2.36M2.11M784K884K1.1M352K639K325K179K324K484K000000000000
Taxes Paid1.98M14.35M4.83M4.93M7.62M12.21M7.68M9.86M9.18M8.54M10.58M7.78M9.25M4.11M6.36M9.04M7.8M8.45M4.4M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Cash flow volatility masking earnings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Earnings Quality Masked by Cash Conversion

Operating cash flow consistently and significantly exceeds net income, with a 10-quarter average OCF/NI ratio of 1.64, suggesting strong cash conversion quality and substantial non-cash charges like depreciation and SBC bolstering cash generation, as indicated by reported financial results.

The persistent gap between net income and operating cash flow indicates the business model generates far more cash than GAAP profits suggest, primarily due to depreciation and share-based compensation. This pattern implies the net loss in Q1 2026 may not reflect underlying cash profitability, though investors should monitor if this conversion quality holds during periods of severe working capital pressure.

Volatile FCF Trajectory Undermines Earnings

Free cash flow has swung wildly from -$7.3M in Q1 2025 to $31.6M in Q2 2025, with the FCF margin ranging from -4.8% to 19.7%, indicating a volatile trajectory that decouples from the more stable, though recently negative, net income trend, as per the company's quarterly disclosures.

This volatility suggests FCF is driven more by timing of working capital and acquisition payments than by underlying operational profitability. The decoupling from net income means recent net losses do not necessarily signal cash burn, but the erratic trajectory creates significant uncertainty for forecasting sustainable free cash generation.

Working Capital Drains Destroy Cash

Working capital consumed $74.4M over the last ten quarters, with massive outflows of $28.3M and $19.4M in Q1 2025 and Q1 2026 respectively, representing a primary source of cash flow volatility that appears to overwhelm operating profitability, based on the provided cash flow statements.

The persistent negative working capital changes indicate the company may be struggling to collect receivables or is prepaying expenses, a pattern that severely undermines cash generation. These drains are likely seasonal but their magnitude suggests a structural issue in managing the cash conversion cycle, directly contradicting any positive signals from operating income.

Aggressive Deployment Limits Cash Accumulation

Capital deployment has been aggressive, with $52.5M spent on acquisitions and $53.7M on dividends and buybacks over the last ten quarters, which has consumed the majority of generated operating cash flow and limited the net cash position despite strong OCF, according to the company's reported financing activities.

Management's commitment to shareholder returns via dividends and a recent $19.2M buyback in Q2 2026, alongside significant M&A, suggests a strategy of aggressive capital deployment rather than cash accumulation. This approach leaves limited buffer to fund operations or absorb further working capital shocks, heightening financial risk.

SBC and Acquisition Distortions

Reported operating cash flow includes $13.6M of stock-based compensation over four quarters, a non-cash add-back, while the $93.4M acquisition in Q4 2024 and subsequent deals significantly distort cash flow from operations and investing, potentially obscuring the underlying organic cash generation ability, as seen in the financial statements.

SBC, while non-cash, represents real dilution and future cash obligations, making it a critical adjustment for true cash earnings analysis. Furthermore, the large acquisition spending obscures the maintenance cash needs of the business, making it difficult to assess whether operating cash flow is sufficient to fund both growth and normal capital replacement.

USPH — Frequently Asked Questions

Quick answers to the most common questions about buying USPH stock.

How much cash does U.S. Physical Therapy, Inc. (USPH) generate from operations?

U.S. Physical Therapy, Inc. (USPH) generated $75.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is U.S. Physical Therapy, Inc.'s free cash flow?

U.S. Physical Therapy, Inc. (USPH) generated $61.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is U.S. Physical Therapy, Inc.'s capital expenditure (CapEx)?

U.S. Physical Therapy, Inc. (USPH) spent $14.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does U.S. Physical Therapy, Inc. distribute cash to shareholders?

In 2025, U.S. Physical Therapy, Inc. (USPH) returned $27.4M to shareholders via cash dividends and spent $5.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.